Sarah Fox, MD
Surgery · Wilmington, NCNPI 1376988360
Payments from drug & device makers
Across 72 payments — averaging $127.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$6K
- Medtronic$1K
- THD America, Inc.$378
- TELA Bio, Inc.$277
- Boston Scientific$242
- Kerecis Limited$166
- plus $598 from 12 others
What the payments were for
- Speaking & faculty fees$5,00055%
- Travel & lodging$8499%
- Food & beverage$3,25036%
- Gifts$280%
- Entertainment$220%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 11 | $6,223 |
| Medtronic | 19 | $1,265 |
| THD America, Inc. | 1 | $378 |
| TELA Bio, Inc. | 11 | $277 |
| Boston Scientific | 4 | $242 |
| Kerecis Limited | 2 | $166 |
| Smith+Nephew | 6 | $153 |
| Johnson & Johnson | 3 | $119 |
| AbbVie | 2 | $59 |
| Davol Inc. | 3 | $57 |
| Merck | 3 | $51 |
| Scilex Pharmaceuticals Inc. | 1 | $34 |
| Vertex | 1 | $25 |
| Musculoskeletal Transplant Foundation Inc. | 1 | $22 |
| Sanara Medtech Inc. | 1 | $22 |
| KCI USA, Inc. | 1 | $21 |
| Acell, Inc. | 1 | $20 |
| Solventum Corporation | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$9,150 in reported general payments places this provider in the 70th percentile of 970 surgery providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Neomycin Sulfate | 27 | $93 |
| Metronidazole | 28 | $26 |
Paid to pharmacies, not to this prescriber.
Other surgery in Wilmington
- William HopeWilmington$761K
- Mark MedleyWilmington$206K
- Kamran GoudarziWilmington$132K
- Zachary WilliamsWilmington$118K
- Jacob SchroderDurham$2.6M
- Samuel RossCharlotte$2.6M
- Jacob GreenbergDurham$1.3M
- Brant HenifordCharlotte$963K
- Vedra AugensteinCharlotte$789K
- John MartinieCharlotte$712K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.